MacroGenics, Inc. (MGNX)

Oncology Corporate Profile

Stock Performance

21.0800
-0.3000

HQ Location

9640 Medical Center Drive
Rockville, MD 20850

Company Description

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 150+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer and other serious, complex diseases. Our products and platforms have attracted multiple partnerships with leading pharmaceutical companies around the globe.

Website: http://www.macrogenics.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
margetuximabanti-HER2 monoclonal antibodyBreast cancerIIIGreen Cross
margetuximabanti-HER2 monoclonal antibodyBreast cancerIIGreen Cross
margetuximab (+pembrolizumab)anti-HER2 monoclonal antibodyGastric cancerIIGreen Cross
MGD006dual-affinity re-targeting (DART) moleculeAcute Myelogenous Leukemia (AML)IServier
MGD007dual-affinity re-targeting (DART) moleculeColorectal cancerIServier
MGD011bispecific dual-affinity re-targeting (DART) moleculeLymphomaIJanssen
MGD006dual-affinity re-targeting (DART) moleculeMyelodysplastic Syndrome (MDS)IServier
MGD009dual-affinity re-targeting (DART) moleculeVarious cancer typesI
enoblituzumab / MGA271monoclonal antibodyVarious cancer typesI

View additional information on product candidates here »

Source: http://www.macrogenics.com/

Recent News Headlines

5/22/2017 12:18 pm

5/22/2017 12:18 pm

5/22/2017 12:18 pm

5/22/2017 12:18 pm

5/22/2017 12:18 pm

5/9/2017 06:18 am

5/9/2017 06:18 am

5/9/2017 06:18 am

5/9/2017 06:18 am

5/9/2017 06:18 am

5/8/2017 12:19 pm

5/8/2017 12:19 pm

5/8/2017 12:19 pm

5/8/2017 12:19 pm

5/8/2017 12:19 pm

5/5/2017 06:18 am

5/5/2017 06:18 am

5/5/2017 06:18 am

5/5/2017 06:18 am

5/5/2017 06:18 am

5/3/2017 12:18 pm

4/26/2017 12:18 am

Eight Posters Based on MacroGenics-developed Molecules Featured at AACR Annual Meeting 2017

3/31/2017 11:03 am

[GlobeNewswire] - Rockville, MD, March 31, 2017--. MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment ...

MacroGenics to Present at the Needham Healthcare Conference

3/29/2017 09:03 pm

[GlobeNewswire] - Rockville, MD, March 29, 2017--. MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment ...